Sol-Gel Technologies Ltd. (SLGL)
Develops topical creams treating acne, rosacea, and rare skin disorders.
$83.07+0.04%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+539.0%
The outlook
Sol-Gel Technologies is trading near the top of its 52-week range, well above its longer-term moving averages. Analyst consensus is unanimously "Strong Buy" with an average price target about 132% above the current price. The stock shows strong technical positioning, though it's already elevated from recent lows.
What’s behind the score
Analyst consensusStrong Buy — 1.0 avg of 3 analysts
Price trendAbove its 50- & 200-day averages
52-week range83% of the way from its 52-week low to high
Price targetAvg target +132% vs current price
Analyst price target
~12-month · 3 analysts$193.00average target+132.3% vs now
Now $83.07
Low $110.00High $285.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$271.6M
52-wk high
$97.97
52-wk low
$10.77
50-day avg
$75.09
200-day avg
$63.50
Trailing P/E
—